Categories Consumer, Earnings

H&R Block stock drops after Q2 loss widens; revenues beat estimates

H&R Block (HRB) Thursday reported a wider net loss for the second quarter of 2019, owing to higher expenses and seasonal factors that more than offset a rise in revenues. Though the results came in above estimates, shares of the tax consultancy firm dropped modestly in premarket trading.

Net loss from continuing operations, adjusted for one-time items, widened to $171 million or $0.83 per share from $148 million or $0.71 per share in the second quarter of 2018. Analysts were looking for a bigger loss.

Meanwhile, revenues moved up 6% to $148.9 million in the second quarter from $140.8 million in the same period last year and exceeded analysts’ forecast, aided by a marked increase in Assisted Tax preparation and the timing of revenues from Tax Plus products. There was a 2% rise in operating costs to $364 million, mainly reflecting higher occupancy and compensation expenses.

Revenues rose 6%, aided by a marked increase in Assisted Tax preparation and the timing of revenues from Tax Plus products

“The fiscal second-quarter results reflect planned increases in expenses related to strategic investments being made in the business. We are focused on executing the operational elements of our strategy for the upcoming tax season, and remain on track to achieve our financial outlook for the fiscal year,” said H&R Block CFO Tony Bowen.

H&R Block stock plunge 11% despite Q4 earnings and revenue beat

The management said it is making various preparations for the upcoming tax season, including virtual tax innovations and measures to ensure transparent pricing in all of the company’s channels.

H&R Block shares dropped about 5% in the past six months, underperforming the S&P 500. The stock closed the last trading session lower and lost further in the premarket trading Thursday after the earnings report.

 

Get access to timely and accurate verbatim transcripts that are published within hours of the event

Most Popular

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Walgreens Boots Alliance set to report earnings next week. Here’s what to expect

Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the drug store chain that is expanding into a diversified healthcare provider, is on a restructuring drive aimed at better aligning the business with

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top